ArticleJournal for immunotherapy of cancer2022

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer.

Manu Prasad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.